The position As a Business Insights Senior Analyst, you will: Support the BI Manager and the team in centralizing and managing a variety of data and information through the creation of dashboards and KPIs. Proactively assist in the development and execution of content and solutions with clear storylines to enhance customer performance by targeting segmented databases. Craft a clear narrative and use it to develop recommendations related to analytics and data together with the BI Manager. Collaborate on qualitative and quantitative marketing research projects by analyzing data trends (e.g., prescriber, patient, payer data). Maintain and develop databases and analytic applications in collaboration with IT, utilizing environments such as Power BI, Haystack, Qlik, Excel, and/or other proprietary platforms. Assist the BI Manager in developing reporting tools and reports (dashboards, search e.g. Google, or chat e.g. ChatGPT) for senior management to monitor strategic initiatives for all business units. Qualifications To be our new Business Insights Senior Analyst, we are looking for a candidate with the following qualifications: A Bachelor's degree is required, preferably with a focus in Business, Marketing, or Engineering. Knowledge in ETL and Data Representation Tools such as Alteryx, Python, SQL, QlikView, PowerBI (among others) is a plus. Proficiency in English. At least 2 years of experience in the area or similar roles. About the department The Commercial Excellence department at Novo Nordisk is dedicated to driving business intelligence and optimizing effectiveness. Our team of data analysts and insights professionals work closely with key stakeholders to provide data-based insights that support business decision-making. We analyze data, identify trends, and prepare reports and visualizations to aid in data storytelling. By leveraging the power of data, we strive to continuously improve our business strategies and outcomes. Working at Novo Nordisk Novo Nordisk is a leading global healthcare company with a -year legacy of driving change to defeat serious chronic diseases. Building on our strong legacy within diabetes, we are growing massively and expanding our commitment, reaching millions around the world and impacting more than 40 million patient lives daily. All of this has made us one of the 20 most valuable companies in the world by market cap. Our success relies on the joint potential and collaboration of our more than 63, employees around the world. We recognize the importance of the unique skills and perspectives our people bring to the table
